EKTA-B 📈 Elekta AB (publ) - Overview

Elekta AB (publ) is a medical technology company that specializes in providing clinical solutions for the treatment of cancer and brain disorders on a global scale. The company's product portfolio includes a range of radiation therapy products, such as the Elekta Unity, which enables real-time MR visualization, and the Elekta Versa HD, a solution specifically designed for treating brain metastases. Additionally, Elekta offers the Elekta Harmony, a linear accelerator, and the Elekta Infinity, which can be used to treat patients with simple to complex radiotherapy needs. The company also provides quality assurance, treatment, and motion management solutions to ensure accurate and effective treatment delivery.

The company's stereotactic radiosurgery product line includes the Elekta Esprit, the Leksell Gamma Knife Icon, which provides personalized radiation treatment, and the Leksell Gamma Knife Perfexion, a tool designed for radiosurgeons. The Leksell GammaPlan is a treatment planning and management software that complements these products. Furthermore, Elekta offers the Elekta ONE, a software suite that integrates multiple Elekta solutions, providing a comprehensive platform for cancer treatment. The company's commitment to innovation is evident in its continuous development of new products and solutions, such as the Elekta Unity, which has revolutionized the field of radiation therapy with its real-time MR visualization capabilities.

In the area of brachytherapy, Elekta provides a range of products, including the Elekta Studio, an image-guided brachytherapy solution, and the ImagingRing, a mobile CT scanner. The Oncentra Brachy is a smart tool that facilitates repetitive tasks, while the Elekta Xoft Axxent is an electronic brachytherapy system. The company also offers the Elekta Geneva, an applicator for cervical cancer patients, and the Flexitron afterloader, which enables the precise execution of all steps in the workflow. The Venezia applicator is another product that enables oncologists to treat locally advanced cervical cancer. These products demonstrate Elekta's focus on providing comprehensive solutions for cancer treatment, from diagnosis to therapy.

Elekta's neurosurgery product line includes the Leksell Vantage Stereotactic System, which is designed for intracranial neurosurgery. The company also provides the Elekta Kaiku, a solution for personalized cancer care, and veterinary radiation therapy solutions. With a history dating back to 1972, Elekta AB (publ) is headquartered in Stockholm, Sweden, and is a leading player in the medical technology industry, with a strong focus on innovation and customer satisfaction. The company's products and solutions are designed to improve patient outcomes and enhance the quality of life for individuals affected by cancer and brain disorders.

As a publicly traded company, Elekta AB (publ) is listed on the Stockholm stock exchange, and its common stock is classified under the GICS Sub Industry: Life Sciences Tools & Services. The company's ISIN is SE0000163628, and its web URL is https://elekta.com. With a strong presence in the global market, Elekta AB (publ) continues to innovate and expand its product portfolio, providing comprehensive solutions for the treatment of cancer and brain disorders. The company's commitment to research and development has enabled it to stay at the forefront of the medical technology industry, and its products and solutions have improved the lives of countless individuals worldwide.